Metformin: Current knowledge
Erratum in
-
Erratum: Metformin: Current knowledge.J Res Med Sci. 2024 Jan 30;29:6. doi: 10.4103/JRMS.JRMS_62_24. eCollection 2024. J Res Med Sci. 2024. PMID: 38524744 Free PMC article.
Abstract
Diabetes mellitus is a group of metabolic disorders in which the blood glucose is higher than normal levels, due to insufficiency of insulin release or improper response of cells to insulin, resulting in high blood pressure. The resultant hyperglycemia produces sever complications. Metformin drug has been shown to prevent diabetes in people who are at high risk and decrease most of the diabetic complications. Recent reports on metformin, not only indicate some implications such as renoprotective properties have been suggested for metformin, but some reports indicate its adverse effects as well that are negligible when its benefits are brought into account. We aimed here to review the new implications of metformin and discuss about the concerns in the use of metformin, referring to the recently published papers.
Keywords: Diabetes; diabetes mellitus; diabetic nephropathy; glucose; metformin; new applications; polycystic ovary syndrome; renoprotection.
Conflict of interest statement
References
-
- Scheen AJ, Paquot N. Metformin revisited: A critical review of the benefit-risk balance in at-risk patients with type 2 diabetes. Diabetes Metab. 2013;39:179–90. - PubMed
-
- Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: An update. Ann Intern Med. 2002;137:25–33. - PubMed
-
- Hundal RS, Inzucchi SE. Metformin: New understandings, new uses. Drugs. 2003;63:1879–94. - PubMed
-
- Scarpello JH, Howlett HC. Metformin therapy and clinical uses. Diab Vasc Dis Res. 2008;5:157–67. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources